Increased expression of Na+/H+ exchanger isoform 1 predicts tumor aggressiveness and unfavorable prognosis in epithelial ovarian cancer

Haixia Wang(Capital Medical University), Qi Zhou(Fudan University), Dongling Zou(Chongqing Cancer Hospital), Dong Wang(Zhejiang Chinese Medical University), Meng Lou(Army Medical University), Weiqi Nian(Chongqing University), Xingtao Long(Chongqing University), Rui Chen(Scuola Superiore Sant'Anna)
Oncology Letters
September 25, 2018
10.3892/ol.2018.9500
Cited by 13

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
|Journal of Neuroinflammation|2022|517
Drug resistance in ovarian cancer: from mechanism to clinical trial
|Molecular Cancer|2024|233
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212
Systemic clearance of <i>p16<sup>INK4a</sup></i>‐positive senescent cells mitigates age‐associated intervertebral disc degeneration
|Aging Cell|2019|170